1996 - PhD Genetics, University of Edinburgh
1991 - BSc (Hons) Biotechnology, University of London
Dr Allen is a biologist with particular experience in the fields of biotechnology, neuroscience, developmental biology, genetics and evolutionary biology, immunology, and virology. His PhD studies involved molecular genetic analysis of mouse mutations that affect limb development and that shed light on the evolutionary mechanisms of morphogenesis. From 1996 to 2004, Dr Allen was a senior researcher at the Department of Neurobiology, The Babraham Institute, Cambridge, UK, where he worked on the cell biology, biochemistry, pharmacology, endocrinology, immunology, and cancer biology of the neuropeptide somatostatin. He was also involved in projects to generate and analyze mouse models of neurodegenerative disease, including Parkinson’s and Alzheimer’s diseases. Dr Allen’s areas of expertise include embryonic development and stem cell biology, G-protein-coupled receptors and cell signaling, mouse and human molecular genetics, genome engineering, viral vectors and ‘omics’ technologies, molecular neuroscience and neuroanatomy, mouse behavioral testing, and a wide range of molecular biological techniques. Dr Allen has extensive experience of writing scientific manuscripts and successful grant proposals and has peer-reviewed many manuscripts for biomedical journals. He joined Edanz as an editor in 2007 and has edited over 1600 manuscripts.
Dr Allen has authored multiple peer-reviewed papers in journals including The Journal of Neuroscience, The European Journal of Neuroscience, and Genomics.
Editing and Reviewing Experience
Dr Allen has edited many manuscripts and grant proposals for colleagues. He has edited over 1600 manuscripts for Edanz and has been a reviewer for The Journal of Physiology, Brain Research, Kidney International, Naunyn-Schmiedeberg's Archives of Pharmacology, and Movement Disorders.